TrialMedical oncology (Northwood, London, England)2015

Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.